Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 25;15(8):207.
doi: 10.3390/jfb15080207.

Iron Oxide Nanoparticles: Parameters for Optimized Photoconversion Efficiency in Synergistic Cancer Treatment

Tsenka Grancharova  1   2 , Plamen Zagorchev  1   2 , Bissera Pilicheva  2   3
Affiliations
Review

Iron Oxide Nanoparticles: Parameters for Optimized Photoconversion Efficiency in Synergistic Cancer Treatment

Tsenka Grancharova et al. J Funct Biomater. .

Abstract

Photothermal therapy (PTT) can overcome cancer treatment resistance by enhancing the cell membrane permeability, facilitating drug accumulation, and promoting drug release within the tumor tissue. Iron oxide nanoparticles (IONPs) have emerged as effective agents for PTT due to their unique properties and biocompatibility. Approved for the treatment of anemia, as MRI contrast agents, and as magnetic hyperthermia mediators, IONPs also offer excellent light-to-heat conversion and can be manipulated using external magnetic fields for targeted accumulation in specific tissue. Optimizing parameters such as the laser wavelength, power density, shape, size, iron oxidation state, functionalization, and concentration is crucial for IONPs' effectiveness. In addition to PTT, IONPs enhance other cancer treatment modalities. They improve tumor oxygenation, enhancing the efficacy of radiotherapy and photodynamic therapy. IONPs can also trigger ferroptosis, a programmed cell death pathway mediated by iron-dependent lipid peroxidation. Their magneto-mechanical effect allows them to exert a mechanical force on cancer cells to destroy tumors, minimizing the damage to healthy tissue. This review outlines strategies for the management of the photothermal performance and PTT efficiency with iron oxide nanoparticles, as well as synergies with other cancer therapies.

Keywords: cancer; iron oxide; nanomedicine; nanoparticles; photothermia; synergistic; theranostic.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The role of hyperthermia in cancer therapy. Created with Biorender.com.
Figure 2
Figure 2
Application of IONPs in cancer therapy. Created with Biorender.com.
Figure 3
Figure 3
Parameters that affect the photothermal performance of IONPs. Created with Biorender.com.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Su J.X., Li S.J., Zhou X.F., Zhang Z.J., Yan Y., Liu S.L., Qi Q. Chemotherapy-induced metastasis: Molecular mechanisms and clinical therapies. Acta Pharmacol. Sin. 2023;44:1725–1736. doi: 10.1038/s41401-023-01093-8. - DOI - PMC - PubMed
    1. Tohme S., Simmons R.L., Tsung A. Surgery for cancer: A trigger for metastases. Cancer Res. 2017;77:1548–1552. doi: 10.1158/0008-5472.CAN-16-1536. - DOI - PMC - PubMed
    1. Liu Y., Zheng C., Huang Y., He M., Xu W.W., Li B. Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment. MedComm. 2021;2:315–340. doi: 10.1002/mco2.55. - DOI - PMC - PubMed
    1. Zein R., Sharrouf W., Selting K. Physical Properties of Nanoparticles That Result in Improved Cancer Targeting. J. Oncol. 2020;2020:5194780. doi: 10.1155/2020/5194780. - DOI - PMC - PubMed
    1. Wang R., Billone P.S., Mullett W.M. Nanomedicine in action: An overview of cancer nanomedicine on the market and in clinical trials. J. Nanomater. 2013;2013:12. doi: 10.1155/2013/629681. - DOI

LinkOut - more resources